Literature DB >> 29346043

Analysis of Margin Classification Systems for Assessing the Risk of Local Recurrence After Soft Tissue Sarcoma Resection.

Kenneth R Gundle1, Lisa Kafchinski1, Sanjay Gupta1, Anthony M Griffin1, Brendan C Dickson1, Peter W Chung1, Charles N Catton1, Brian O'Sullivan1, Jay S Wunder1, Peter C Ferguson1.   

Abstract

Purpose To compare the ability of margin classification systems to determine local recurrence (LR) risk after soft tissue sarcoma (STS) resection. Methods Two thousand two hundred seventeen patients with nonmetastatic extremity and truncal STS treated with surgical resection and multidisciplinary consideration of perioperative radiotherapy were retrospectively reviewed. Margins were coded by residual tumor (R) classification (in which microscopic tumor at inked margin defines R1), the R+1mm classification (in which microscopic tumor within 1 mm of ink defines R1), and the Toronto Margin Context Classification (TMCC; in which positive margins are separated into planned close but positive at critical structures, positive after whoops re-excision, and inadvertent positive margins). Multivariate competing risk regression models were created. Results By R classification, LR rates at 10-year follow-up were 8%, 21%, and 44% in R0, R1, and R2, respectively. R+1mm classification resulted in increased R1 margins (726 v 278, P < .001), but led to decreased LR for R1 margins without changing R0 LR; for R0, the 10-year LR rate was 8% (range, 7% to 10%); for R1, the 10-year LR rate was 12% (10% to 15%) . The TMCC also showed various LR rates among its tiers ( P < .001). LR rates for positive margins on critical structures were not different from R0 at 10 years (11% v 8%, P = .18), whereas inadvertent positive margins had high LR (5-year, 28% [95% CI, 19% to 37%]; 10-year, 35% [95% CI, 25% to 46%]; P < .001). Conclusion The R classification identified three distinct risk levels for LR in STS. An R+1mm classification reduced LR differences between R1 and R0, suggesting that a negative but < 1-mm margin may be adequate with multidisciplinary treatment. The TMCC provides additional stratification of positive margins that may aid in surgical planning and patient education.

Entities:  

Mesh:

Year:  2018        PMID: 29346043     DOI: 10.1200/JCO.2017.74.6941

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  29 in total

Review 1.  Extremity Soft Tissue Sarcoma: Role of Local Control.

Authors:  Elyse J Brinkmann; Safia K Ahmed; Matthew T Houdek
Journal:  Curr Treat Options Oncol       Date:  2020-02-05

Review 2.  Diagnosis and Management of Subcutaneous Soft Tissue Sarcoma.

Authors:  Makoto Endo; Nokitaka Setsu; Toshifumi Fujiwara; Takeaki Ishii; Makoto Nakagawa; Kenichiro Yahiro; Atsushi Kimura; Eijiro Shimada; Yasuharu Nakashima; Yoshihiro Matsumoto
Journal:  Curr Treat Options Oncol       Date:  2019-05-25

Review 3.  [Systematic planning of surgery for soft tissue sarcoma of the extremities].

Authors:  J Jakob; J Schmolders
Journal:  Chirurg       Date:  2019-06       Impact factor: 0.955

4.  Prognostic factors of the synovial sarcoma of the extremities: imaging does matter.

Authors:  Mickael Tordjman; Charles Honoré; Amandine Crombé; Amine Bouhamama; Antoine Feydy; Laurent Dercle; Leila Haddag; Pierre-Alban Bouché; Carine Ngo; Axel Le Cesne; Jean-Yves Blay; Olivier Mir; Mehdi Brahmi; Charlotte Martin; Marie Karanian; Samy Ammari; Michele Kind; Virginie Audard; François Le Loarer; Behnam Rabiee; Antoine Italiano; Pascaline Boudou-Rouquette; David Biau; Corinne Balleyguier; Frederique Larousserie; Jean-Luc Drapé; Fadila Mihoubi
Journal:  Eur Radiol       Date:  2022-08-18       Impact factor: 7.034

Review 5.  Radiation Therapy for Soft Tissue Sarcoma: Indications, Timing, Benefits, and Consequences.

Authors:  Kilian E Salerno
Journal:  Surg Clin North Am       Date:  2022-06-24       Impact factor: 3.537

6.  Local Recurrence of Soft Tissue Sarcoma Revisited: Is there a Role for "Selective" Radiation?

Authors:  Nathan E Saxby; Qiang An; Benjamin J Miller
Journal:  Iowa Orthop J       Date:  2022-06

7.  Designing a Rational Follow-Up Schedule for Patients with Extremity Soft Tissue Sarcoma.

Authors:  David A J Wilson; Aaron Gazendam; Julia Visgauss; David Perrin; Anthony M Griffin; Peter W Chung; Charles N Catton; David Shultz; Peter C Ferguson; Jay S Wunder
Journal:  Ann Surg Oncol       Date:  2020-03-09       Impact factor: 5.344

8.  Inhibition of P53-mediated cell cycle control as the determinant in dedifferentiated liposarcomas development.

Authors:  Mossane Stocker; Louis-Romée Le Nail; Hubert De Belenet; Jay S Wunder; Irene L Andrulis; Nalan Gokgoz; Nicolas Levy; Jean-Camille Mattei; Sylviane Olschwang
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

9.  Clinical features and outcomes of metastatic bone tumors of the pelvis.

Authors:  Qing Yang; Nong Chen; Wenqin Fu
Journal:  J Int Med Res       Date:  2021-06       Impact factor: 1.671

10.  Characterization of PD-1/PD-L1 immune checkpoint expression in soft tissue sarcomas.

Authors:  Kazuhiko Hashimoto; Shunji Nishimura; Tomohiko Ito; Masao Akagi
Journal:  Eur J Histochem       Date:  2021-07-02       Impact factor: 3.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.